Randomized phase III trial of maintenance bevacizumab with or without pemetrexed after first-line induction with bevacizumab, cisplatin, and pemetrexed in advanced nonsquamous non-small-cell lung cancer: AVAPERL (MO22089). [electronic resource]
Producer: 20131108Description: 3004-11 p. digitalISSN:- 1527-7755
- Adult
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Bevacizumab
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cisplatin -- administration & dosage
- Drug Administration Schedule
- Female
- Glutamates -- administration & dosage
- Guanine -- administration & dosage
- Humans
- Induction Chemotherapy
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Pemetrexed
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.